[
    [
        {
            "time": "",
            "orginal_text": "结核病日 | 新发病例超新冠十倍，传染病死因之首，如何终结TA？",
            "features": {
                "keywords": [
                    "结核病",
                    "新发病例",
                    "新冠",
                    "传染病",
                    "死因"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "公共卫生"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "结核病日 | 新发病例超新冠十倍，传染病死因之首，如何终结TA？",
            "scores": {
                "News_content": "结核病日 | 新发病例超新冠十倍，传染病死因之首，如何终结TA？",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "[快讯]智飞生物子公司研发重组新冠疫苗贡献抗疫安徽力量",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "研发",
                    "抗疫"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[快讯]智飞生物子公司研发重组新冠疫苗贡献抗疫安徽力量",
            "scores": {
                "News_content": "[快讯]智飞生物子公司研发重组新冠疫苗贡献抗疫安徽力量",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "每日理财观察：数字人民币测试进程提速",
            "features": {
                "keywords": [
                    "数字人民币",
                    "测试",
                    "提速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融科技",
                    "数字货币"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "每日理财观察：数字人民币测试进程提速",
            "scores": {
                "News_content": "每日理财观察：数字人民币测试进程提速",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "【医药】结构性机会显现，关注业绩高增长个股――医药行业周报——中性",
            "features": {
                "keywords": [
                    "医药",
                    "结构性机会",
                    "业绩高增长",
                    "个股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【医药】结构性机会显现，关注业绩高增长个股――医药行业周报——中性",
            "scores": {
                "News_content": "【医药】结构性机会显现，关注业绩高增长个股――医药行业周报――中性",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "【东吴晨报0324】【行业】社服【个股】智飞生物、当升科技、博瑞医药、威派格、中伟股份",
            "features": {
                "keywords": [
                    "东吴晨报",
                    "社服",
                    "智飞生物",
                    "当升科技",
                    "博瑞医药",
                    "威派格",
                    "中伟股份"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技",
                    "环保"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【东吴晨报0324】【行业】社服【个股】智飞生物、当升科技、博瑞医药、威派格、中伟股份",
            "scores": {
                "News_content": "【东吴晨报0324】【行业】社服【个股】智飞生物、当升科技、博瑞医药、威派格、中伟股份",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]